Get started
Author

Gabriella Del Bene

Observed names: G. Del Bene, Gabriella del Bene
ORCID: 0000-0002-1002-3607
Observed ORCID: 0000-0002-1002-3607
OpenAlex ID: A5049353036
Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab
2016 · Chiara Nicolazzo, Cristina Raimondi, et al. · Scientific Reports · 290
PDF
Impact of tobacco control interventions on smoking initiation, cessation, and prevalence: a systematic review
2020 · Daniela Bafunno, Annamaria Catino, et al. · Journal of Thoracic Disease · 103
PDF
Regulatory T cells with multiple suppressive and potentially pro-tumor activities accumulate in human colorectal cancer
2016 · Eleonora Timperi, Ilenia Pacella, et al. · OncoImmunology · 87
PDF
EPSILoN: A Prognostic Score Using Clinical and Blood Biomarkers in Advanced Non–Small-cell Lung Cancer Treated With Immunotherapy
2020 · Arsela Prelaj, Sara Elena Rebuzzi, et al. · Clinical Lung Cancer · 72
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial
2023 · Sandro Pignata, Giovanni Scambia, et al. · The Lancet Oncology · 63
Safety and Efficacy of Cabozantinib in Metastatic Renal-Cell Carcinoma: Real-World Data From an Italian Managed Access Program
2018 · Giuseppe Procopio, Michele Prisciandaro, et al. · Clinical Genitourinary Cancer · 43
Neoadjuvant vs. Adjuvant Chemotherapy in Muscle Invasive Bladder Cancer (MIBC): Analysis From the RISC Database
2018 · Gabriella Del Bene, Fabio Calabrò, et al. · Frontiers in Oncology · 39
PDF
Combination of aprepitant, palonosetron and dexamethasone as antiemetic prophylaxis in lung cancer patients receiving multiple cycles of cisplatin‐based chemotherapy
2012 · F. Longo, G. Mansueto, et al. · International Journal of Clinical Practice · 36
PDF
Evaluation of the efficacy of cisplatin–etoposide and the role of thoracic radiotherapy and prophylactic cranial irradiation in LCNEC
2017 · Arsela Prelaj, Sara Elena Rebuzzi, et al. · ERJ Open Research · 29
PDF
Systemic Chemotherapy in Muscle Invasive and Metastatic Bladder Cancer: Present and Future
2017 · Gabriella Del Bene, Cora N. Sternberg · Urologia Journal · 12
Smoking Prevalence, Knowledge and Perceptions on Tobacco Control Among Healthcare Professionals: A Survey in an Italian Cancer Center
2020 · Daniela Bafunno, Annamaria Catino, et al. · Journal of Community Health · 11
Thyroid profile during the alternative Sunitinib dosing 2/1 schedule in metastatic renal cell carcinoma
2019 · L. Rizza, E. Sbardella, et al. · Endocrine · 11
DiM: Prognostic Score for Second- or Further-line Immunotherapy in Advanced Non–Small-Cell Lung Cancer: An External Validation
2020 · Arsela Prelaj, Giuseppe Lo Russo, et al. · Clinical Lung Cancer · 6
PDF
Merkel Cell Carcinoma of the Retroperitoneum with No Identifiable Primary Site
2013 · Daniele Rossini, Salvatore Caponnetto, et al. · Case Reports in Oncological Medicine · 4
PDF
Safety and efficacy of nivolumab for metastatic renal cell carcinoma (mRCC): Real world data from an Italian expanded access program (EAP).
2017 · Ugo De Giorgi, Sarah Scagliarini, et al. · Journal of Clinical Oncology · 3
94P: First-line treatment with cisplatin plus etoposide for small cell lung cancer and large cell neuroendocrine carcinoma: Our center experience
2016 · G. Del Bene, A. Prelaj, et al. · Journal of Thoracic Oncology · 2
PDF
Esophageal Stricture Caused by ALK-Positive NSCLC Esophageal Metastasis Resolved After a Few Days of Lorlatinib Therapy Without Stent Placement
2020 · Vito Longo, Annamaria Catino, et al. · JTO Clinical and Research Reports · 1
PDF
Enzalutamide in patients with castration-refractory prostate cancer: Retrospective, multicenter, real life study
2019 · M. Gacci, M. Marchioni, et al. · European Urology Supplements · 1
EP1.04-38 A Case of Lichenoid Reaction as Late and Uncommon Immune-Related Skin Toxicity During Nivolumab Treatment
2019 · A. Catino, R. Filannino, et al. · Journal of Thoracic Oncology · 1
PDF
MA10.05 Breath Analysis: New Key-Challenges for Early Detection of Lung and Pleural Neoplasms
2019 · A. Catino, G. De Gennaro, et al. · Journal of Thoracic Oncology · 1
Peripheral blood biomarkers as prognostic factors for immunotherapy in advanced non-small cell lung cancer (aNSCLC) patients
2019 · A. Prelaj, S.E. Rebuzzi, et al. · Annals of Oncology · 1
1755P The beginning of the COVID-19 era: The perception of oncological patients (pts) in active treatment at the Brindisi and Mauriziano Hospital Oncology Departments
2020 · D. Loparco, M. Di Maio, et al. · Annals of Oncology
PDF
P2.01-74 Clinical-Pathological Features and Outcome of Patients with Oral Metastases from Lung Cancer: A Multicenter Retrospective Study
2019 · M. Tagliamento, D. Pignataro, et al. · Journal of Thoracic Oncology
PDF
EP1.01-56 Co-Presentation of Adenocarcinoma and Squamous Cell Lung Carcinoma Harbouring ALK Rearrangement in Different Sites
2019 · V. Longo, A. Catino, et al. · Journal of Thoracic Oncology
PDF
Prognostic score for second or further line immunotherapy in advanced non-small cell lung cancer (aNSCLC): An external validation.
2019 · Arsela Prelaj, Giuseppe Lo Russo, et al. · Journal of Clinical Oncology
Works count: 35
Citation count: 816
H-index: 11
I10-index: 12
Year
Topic
Type